Compound Detail
CHEMBL370093
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL370093 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | RDGCWHXJEXJREZ-FMQUCBEESA-N |
1
Targets
2
Activities
1
Assay Types
0
PK Parameters
1
Publications
0
Known Names
Molecular Properties
410.3
MW (Da)
4.81
ALogP
5
HBA
3
HBD
77.0
PSA (Ų)
0.29
QED
0
Ro5 Violations
3
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
EC50 2 meas. best 6.0
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| HFF CHEMBL614071 | EC50 | 6.0 | 5.605 | 1000.0 | 2 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| HFF | EC50 | = | 1000.0 | nM | 6.0 | Effective concentration required to inhibit vaccinia virus plaque formation in h... | 15828843 |
| HFF | EC50 | = | 6200.0 | nM | 5.21 | Effective concentration required to inhibit cowpox virus plaque formation in hum... | 15828843 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 15828843 | 10.1021/jm049147h | HFF | 6 |
Data from ChEMBL 36 via Core Engine